Subtopic Deep Dive
Pharmacist Interventions Polypharmacy
Research Guide
What is Pharmacist Interventions Polypharmacy?
Pharmacist interventions in polypharmacy involve structured medication reviews, reconciliation, and deprescribing led by pharmacists to optimize drug regimens in older adults and reduce adverse outcomes.
Randomized trials and systematic reviews evaluate pharmacist-led services for elderly patients on multiple medications. Cochrane reviews by Patterson et al. (2014, 761 citations) and Rankin et al. (2018, 488 citations) assess interventions like prescription reviews for improving appropriate polypharmacy. Over 10 key studies since 2010 report prevalence, errors, and intervention effects, with citation totals exceeding 4,000.
Why It Matters
Pharmacist interventions reduce readmission risks, as shown in Ravn-Nielsen et al. (2018, JAMA Internal Medicine, 282 citations), where multifaceted pharmacist actions lowered 180-day readmissions by 33% in hospitalized patients. Deprescribing processes by Reeve et al. (2014, 375 citations) minimize adverse drug reactions and hospitalization in older adults. These models support interprofessional care in geriatrics, cutting healthcare costs and improving adherence (Brown et al., 2016, 404 citations).
Key Research Challenges
Limited Clinical Significance
Interventions like medication reviews show slight benefits in reducing prescribing omissions but lack clear evidence for major outcomes like mortality reduction (Patterson et al., 2014, 761 citations). Follow-up periods are often short, limiting long-term impact assessment (Christensen and Lundh, 2016, 295 citations).
High Polypharmacy Prevalence
Polypharmacy affects most older adults, with meta-analysis by Delara et al. (2022, 297 citations) linking it to factors like comorbidities. Pharmacist assessments identify inappropriate medications but struggle with scalability in ambulatory settings (Nightingale et al., 2015, 263 citations).
Post-Discharge Error Rates
Medication errors and harm persist after hospital discharge, as reviewed by Alqenae et al. (2020, 235 citations). In-hospital pharmacist interventions reduce some risks but fail to prevent community readmissions consistently (Ravn-Nielsen et al., 2018).
Essential Papers
Interventions to improve the appropriate use of polypharmacy for older people
Susan Patterson, Cathal Cadogan, Ngaire Kerse et al. · 2014 · Cochrane Database of Systematic Reviews · 761 citations
It is unclear whether interventions to improve appropriate polypharmacy, such as reviews of patients' prescriptions, resulted in clinically significant improvement; however, they may be slightly be...
Medication Adherence: Truth and Consequences
Marie T. Brown, Jennifer K. Bussell, Suparna Dutta et al. · 2016 · The American Journal of the Medical Sciences · 404 citations
Review of deprescribing processes and development of an evidence‐based, patient‐centred deprescribing process
Emily Reeve, Sepehr Shakib, Ivanka Hendrix et al. · 2014 · British Journal of Clinical Pharmacology · 375 citations
Inappropriate use of medication is widespread, especially in older people, and is associated with risks, including adverse drug reactions, hospitalization and increased mortality. Optimization of a...
Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis
Mahin Delara, Lauren Murray, Behnaz Jafari et al. · 2022 · BMC Geriatrics · 297 citations
Medication review in hospitalised patients to reduce morbidity and mortality
Mikkel Christensen, Andreas Lundh · 2016 · Cochrane Database of Systematic Reviews · 295 citations
We found no evidence that medication review reduces mortality or hospital readmissions, although we did find evidence that medication review may reduce emergency department contacts. However, becau...
Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission
Lene Vestergaard Ravn‐Nielsen, Marie-Louise Duckert, Mia Lolk Lund et al. · 2018 · JAMA Internal Medicine · 282 citations
clinicaltrials.gov Identifier: NCT03079375.
Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer
Ginah Nightingale, Emily Hajjar, Kristine Swartz et al. · 2015 · Journal of Clinical Oncology · 263 citations
Purpose The use of multiple and/or inappropriate medications in seniors is a significant public health problem, and cancer treatment escalates its prevalence and complexity. Existing studies are li...
Reading Guide
Foundational Papers
Start with Patterson et al. (2014, 761 citations) for intervention overview, then Reeve et al. (2014, 375 citations) for deprescribing process, and Page (2010, 219 citations) for PIM tools in hospitalized elderly.
Recent Advances
Rankin et al. (2018, 488 citations) updates polypharmacy interventions; Ravn-Nielsen et al. (2018, 282 citations) shows readmission reductions; Delara et al. (2022, 297 citations) quantifies prevalence.
Core Methods
Randomized trials test medication reviews and reconciliation; tools include Beers Criteria (Page 2010); outcomes measured via readmission rates, adherence scores, and GRADE-assessed meta-analyses.
How PapersFlow Helps You Research Pharmacist Interventions Polypharmacy
Discover & Search
Research Agent uses searchPapers and citationGraph to map high-citation Cochrane reviews like Patterson et al. (2014) and its 2018 update by Rankin et al., then findSimilarPapers reveals 50+ related trials on pharmacist deprescribing. exaSearch queries 'pharmacist polypharmacy interventions elderly RCTs' for hidden gems beyond OpenAlex.
Analyze & Verify
Analysis Agent applies readPaperContent to extract effect sizes from Ravn-Nielsen et al. (2018), verifies claims with CoVe against GRADE criteria for RCTs, and runs PythonAnalysis to meta-analyze readmission rates across Christensen and Lundh (2016) and similar studies using pandas for forest plots.
Synthesize & Write
Synthesis Agent detects gaps in long-term outcomes from gap detection on Cochrane reviews, flags contradictions between Patterson (2014) and recent trials, then Writing Agent uses latexEditText, latexSyncCitations for 20 papers, and latexCompile to generate a review manuscript with exportMermaid for intervention flowcharts.
Use Cases
"Run meta-analysis on readmission rates from pharmacist polypharmacy interventions in RCTs."
Research Agent → searchPapers('polypharmacy pharmacist RCT readmission') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on extracted HRs from Ravn-Nielsen 2018 et al.) → researcher gets CSV of pooled risk ratios with CI.
"Draft LaTeX systematic review on deprescribing in elderly polypharmacy."
Synthesis Agent → gap detection on Reeve 2014 + Cochrane → Writing Agent → latexEditText(structured abstract) → latexSyncCitations(15 papers) → latexCompile → researcher gets PDF review with citations and deprescribing flowchart.
"Find open-source tools for polypharmacy risk scoring from papers."
Research Agent → paperExtractUrls('polypharmacy scoring tools') → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets validated GitHub repo with Beers Criteria calculator linked to Page 2010 PIM tools.
Automated Workflows
Deep Research workflow scans 50+ polypharmacy papers via searchPapers → citationGraph → structured GRADE-graded report on pharmacist intervention efficacy (Patterson 2014 baseline). DeepScan's 7-step chain analyzes Ravn-Nielsen (2018) with CoVe checkpoints, runPythonAnalysis for survival curves, and methodology critique. Theorizer generates hypotheses on interprofessional models from Delara (2022) prevalence data.
Frequently Asked Questions
What defines pharmacist interventions in polypharmacy?
These include medication reviews, reconciliation, and deprescribing to optimize regimens in older adults, as synthesized in Patterson et al. (2014 Cochrane review, 761 citations).
What methods reduce polypharmacy harms?
Multifaceted in-hospital interventions like those in Ravn-Nielsen et al. (2018) cut readmissions; patient-centered deprescribing follows Reeve et al. (2014) process.
What are key papers on this topic?
Foundational: Patterson et al. (2014, 761 citations), Reeve et al. (2014, 375 citations); recent: Rankin et al. (2018, 488 citations), Delara et al. (2022, 297 citations).
What open problems exist?
Short follow-ups limit mortality evidence (Christensen and Lundh, 2016); scalable post-discharge interventions needed beyond hospital settings (Alqenae et al., 2020).
Research Pharmaceutical Practices and Patient Outcomes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pharmacist Interventions Polypharmacy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers